{"id":"W2554281799","doi":"10.1212/wnl.86.16_supplement.p3.023","title":"Results from the 48-Week Blinded Extension of RADIANCE: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Oral Ozanimod in Relapsing Multiple Sclerosis (P3.023)","year":2016,"lang":"en","type":"article","venue":"Neurology","topic":"Fungal Plant Pathogen Control","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Double blind; Randomized controlled trial; Multiple sclerosis; Single blind; Radiance; Physical therapy; Internal medicine; Pathology; Alternative medicine; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307073,0.002104996,0.003616804,0.0003995519,0.0006073881,0.0007947546,0.001015228,0.001997233,0.006303806],"category_scores_gemma":[0.002422353,0.00077387,0.001532143,0.0003496917,0.001078931,0.001037419,0.0005072452,0.002617054,0.001047862],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005317126,"about_ca_system_score_gemma":0.00144806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007216522,"about_ca_topic_score_gemma":0.001767099,"domain_scores_codex":[0.9986064,0.000798726,0.0001112444,0.0002091015,0.0001062417,0.0001684069],"domain_scores_gemma":[0.9980752,0.000408481,0.0005362622,0.0002387301,0.0002017812,0.0005395082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9759113,0.008874283,0.00032633,0.0003180436,0.0003949747,0.00002438156,0.00003849244,0.0001068463,0.00485625,0.00002448131,0.0005822302,0.00854234],"study_design_scores_gemma":[0.9066201,0.08905449,0.002739715,0.00001819993,0.0002862922,0.000024203,0.00000844194,0.0001060705,0.0007459225,0.00003061595,0.0003538822,0.00001196342],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879475,0.001907937,0.0006597949,0.0003294075,0.0001761205,0.005491063,0.001995576,0.0001461205,0.001346468],"genre_scores_gemma":[0.9789321,0.001707065,0.002612823,0.0006943159,0.0004120363,0.008980932,0.003130908,0.00006077028,0.003469133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006303806,"threshold_uncertainty_score":0.02108836,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08626422113115205,"score_gpt":0.2649374497325704,"score_spread":0.1786732286014183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}